Literature DB >> 22341835

Calf muscle hemoglobin oxygen saturation in patients with peripheral artery disease who have different types of exertional leg pain.

Andrew W Gardner1, Donald E Parker, Polly S Montgomery, Aman Khurana, Raphael M Ritti-Dias, Steve M Blevins.   

Abstract

BACKGROUND: This study compared calf muscle hemoglobin oxygen saturation (Sto(2)) and exercise performance during standardized treadmill exercise in patients with peripheral artery disease (PAD) who describe different types of exertional leg pain and compared secondary outcomes consisting of daily ambulatory activity and exercise performance during a 6-minute walk test (6MWT).
METHODS: Leg pain symptoms were evaluated in 114 patients with PAD using the San Diego Claudication Questionnaire, by which atypical exertional leg pain was defined in 31, claudication in 37, and leg pain on exertion and rest in 46. Patients were evaluated on a standardized, graded treadmill test during which calf muscle Sto(2) was continuously monitored. The 6MWT distance, Walking Impairment Questionnaire (WIQ), and ambulatory activity were monitored during 1 week.
RESULTS: All patients experienced symptoms during the treadmill test consistent with claudication. The groups were not significantly different on the primary outcomes of time to reach the minimum calf muscle Sto(2) (P = .350) or peak walking time (P = .238) during treadmill exercise. Patients with atypical leg pain had the highest daily ambulatory activity for total strides per day (P = .032), average daily cadence (P = .010), maximum cadences for durations between 5 minutes (P = .035) and 60 minutes (P = .029), speed score on the WIQ (P = .006), and lowest rating of perceived exertion at the end of the 6MWT (P = .017).
CONCLUSIONS: PAD patients with atypical leg pain have vascular-mediated limitations in exercise performance during standardized treadmill testing similar to patients with claudication and patients with leg pain on exertion and rest but have higher levels of daily ambulatory activity in the community setting and higher perceived ambulatory function.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341835      PMCID: PMC3358574          DOI: 10.1016/j.jvs.2011.12.060

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  31 in total

1.  Impaired muscle oxygen use at onset of exercise in peripheral arterial disease.

Authors:  Timothy A Bauer; Eric P Brass; William R Hiatt
Journal:  J Vasc Surg       Date:  2004-09       Impact factor: 4.268

2.  Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer.

Authors:  M M McDermott; K Liu; E O'Brien; J M Guralnik; M H Criqui; G J Martin; P Greenland
Journal:  Angiology       Date:  2000-02       Impact factor: 3.619

3.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

4.  Progressive vs single-stage treadmill tests for evaluation of claudication.

Authors:  A W Gardner; J S Skinner; B W Cantwell; L K Smith
Journal:  Med Sci Sports Exerc       Date:  1991-04       Impact factor: 5.411

5.  Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Kristy J Scott; Steve M Blevins
Journal:  Circulation       Date:  2011-01-24       Impact factor: 29.690

6.  Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study.

Authors:  W R Hiatt; J A Marshall; J Baxter; R Sandoval; W Hildebrandt; L R Kahn; R F Hamman
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

7.  Effect of weight on claudication distance.

Authors:  M G Wyatt; P M Scott; D J Scott; K Poskitt; R N Baird; M Horrocks
Journal:  Br J Surg       Date:  1991-11       Impact factor: 6.939

8.  Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

Authors:  Mary McGrae McDermott; Kiang Liu; Philip Greenland; Jack M Guralnik; Michael H Criqui; Cheeling Chan; William H Pearce; Joseph R Schneider; Luigi Ferrucci; Lillian Celic; Lloyd M Taylor; Ed Vonesh; Gary J Martin; Elizabeth Clark
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

9.  The ischemic window: a method for the objective quantitation of the training effect in exercise therapy for intermittent claudication.

Authors:  R L Feinberg; R T Gregory; J R Wheeler; S O Snyder; R G Gayle; F N Parent; R B Patterson
Journal:  J Vasc Surg       Date:  1992-08       Impact factor: 4.268

10.  The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study.

Authors:  Mary McGrae McDermott; Philip Greenland; Kiang Liu; Jack M Guralnik; Lillian Celic; Michael H Criqui; Cheeling Chan; Gary J Martin; Joseph Schneider; William H Pearce; Lloyd M Taylor; Elizabeth Clark
Journal:  Ann Intern Med       Date:  2002-06-18       Impact factor: 25.391

View more
  5 in total

1.  Cognitive decrement in older adults with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang; Biyi Shen; Ana I Casanegra; Federico Silva-Palacios; Zoltan Ungvari; Andriy Yabluchanskiy; Anna Csiszar; Shari R Waldstein
Journal:  Geroscience       Date:  2021-09-09       Impact factor: 7.713

2.  Differences in Physical Activity between Patients with Peripheral Artery Disease and Healthy Subjects.

Authors:  Sumiko Shiba; Akiko Shiba; Atsutoshi Hatada
Journal:  J Aging Res       Date:  2020-10-20

3.  The Relationship Between Peripheral Artery Disease Symptomatology and Ischemia.

Authors:  Erica N Schorr; Diane Treat-Jacobson; Ruth Lindquist
Journal:  Nurs Res       Date:  2017 Sep/Oct       Impact factor: 2.381

Review 4.  Methods of symptom evaluation and their impact on peripheral artery disease (PAD) symptom prevalence: a review.

Authors:  Erica N Schorr; Diane Treat-Jacobson
Journal:  Vasc Med       Date:  2013-03-18       Impact factor: 3.239

5.  Microvascular dysfunction and neurovascular uncoupling are exacerbated in peripheral artery disease, increasing the risk of cognitive decline in older adults.

Authors:  Cameron D Owens; Peter Mukli; Tamas Csipo; Agnes Lipecz; Federico Silva-Palacios; Tarun W Dasari; Stefano Tarantini; Andrew W Gardner; Polly S Montgomery; Shari R Waldstein; J Mikhail Kellawan; Adam Nyul-Toth; Priya Balasubramanian; Peter Sotonyi; Anna Csiszar; Zoltan Ungvari; Andriy Yabluchanskiy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.